Double Medical Technology Hits Day Low at CNY 44.65 Amid Price Pressure

Double Medical Technology, Inc. experienced a notable decline today, with the stock dropping by 6.27% on July 17, 2026. The stock reached an intraday low of CNY 44.65, reflecting a challenging day in the market. In terms of performance metrics, Double Medical has shown resilience over the past month, with a gain of 7.35%, contrasting with a decline of 8.37% in the China Shanghai Composite. However, the year-to-date performance indicates a slight downturn, with a decrease of 5.64% compared to the composite's decline of 5.16%. Despite today's drop, the company has reported positive results for the last nine consecutive quarters, showcasing a robust operating cash flow of CNY 879.91 million and net sales growth of 18.01% over the first nine months. The return on equity stands at 17.21%, indicating a fair valuation with a price-to-book ratio of 3.78. Overall, while Double Medical Technology, Inc. faced a setback today, its long-term performance metrics suggest a complex financial landscape within the pharmaceuticals and biotechnology sector.